AzTrials
AzTrials

Emergency Service, HospitalNCT07185828

Informing Low-acuity Emergency Department Patients of Non-emergent Resources (2)

A study testing Contact your PCP and Use Intelligent Triage in people with Emergency Service, Hospital and Behavior Change Interventions, run by Geisinger Clinic at 1 site in United States.

Recruiting

Looking for participants now. Contact the study team or a site below to ask about taking part.

Sites and contacts
Official record
Search all trials

Trial summary

The goal of this campaign is to reduce unnecessary visits to a Geisinger emergency department (ED). In this campaign, patients will be assigned to receive or not receive outreach following ED discharge with a low-acuity visit designation. Read more about this study

Who is it for?
Ages 18 years and older
What is being tested?
Contact your PCP and Use Intelligent Triage
Could I receive a placebo?
No, everyone receives an active treatment
How many people
8,286 participants
Where
1 siteUnited States
Study dates
15 Apr 2025to Jul 2026
Phase
Interventional
Are there results?
Not yet: the study is under way

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 years and older
  • All sexes
  • No healthy volunteers
  • Adult, Older adult

Who may be able to join

  • >= 18 years of age
  • Geisinger ED visit rated as low acuity (L4 or L5)
  • Discharged from Geisinger ED in past 24 hours

Who cannot join

  • Cannot be contacted via the communication modality being used in the study (i.e., SMS), due to insufficient/missing contact information in the EHR or because the patient opted out
  • Admitted to hospital
  • Already included in intervention in past 365 days

Trial locations and contacts

1 site in 1 country. Contact the study team or a site near you to ask about taking part.

Amir Goren, PhD contact

570-214-4395

agoren@geisinger.edu

United States1 site, 1 recruiting
  • Geisinger

    Danville, Pennsylvania, 17822

    Amir Goren, PhD, 570-214-4395, agoren@geisinger.edu

    Recruiting

Other trials in United States

About this study

Official title: Informing Low-acuity Emergency Department Patients of Non-emergent Healthcare Resources Following Discharge to Decrease Emergency Department Utilization (2)

The goal of this campaign is to reduce unnecessary visits to a Geisinger emergency department (ED). In this campaign, patients will be assigned to receive or not receive outreach following ED discharge with a low-acuity visit designation. Outreach will occur via a text message the day after discharge from the ED as well as information added to the patient's after visit summary (AVS). Depending on the assigned condition, it will include calls to see their primary care provider (PCP) or use an Intelligent Triage tool. The study will assess whether ED use within the following 120 days differs across patients in different outreach conditions (current standard practice vs contact your PCP vs use Intelligent Triage). It will also examine whether patients follow through on the message-specific calls to action differently across conditions.

Being tested
Contact your PCP, Use Intelligent Triage
Medical subject headings
Emergencies

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Contact your PCPBehavioural

    Text messages will be sent and discharge paperwork will be modified to encourage contacting a primary care provider.

  • Use Intelligent TriageBehavioural

    Text messages will be sent and discharge paperwork will be modified to encourage using Intelligent Triage.

Study groups in NCT07185828
Study groupRoleWhat they receive
ControlNo interventionThis arm will receive no intervention outside of usual care.
Contact your PCPExperimentalIntervention content emphasizes contacting a primary care provider (content will vary slightly based on whether the patient has a Geisinger PCP)
Receives: Behavioral: Contact your PCP
Use Intelligent TriageExperimentalIntervention content emphasizes using Intelligent Triage to assess symptoms.
Receives: Behavioral: Use Intelligent Triage

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Return to Geisinger ED

    ED visit (yes/no)

    Measured: within 120 days following day of discharge

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted22 Sep 2025
  2. Study start15 Apr 2025
  3. Primary completionJul 2026 (estimated)
  4. Study completionJul 2026 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Health services research
Allocation
Randomised
Intervention model
Parallel groups
Masking
None (open label)
Enrolment
8,286 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT07185828
Sponsor's protocol ID
2024-0183-2
Status last verified
Jul 2026
First submitted
15 Sep 2025
Last updated
23 Jul 2026
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No

Questions about this trial

What is this clinical trial studying?

A study testing Contact your PCP and Use Intelligent Triage in people with Emergency Service, Hospital and Behavior Change Interventions, run by Geisinger Clinic at 1 site in United States.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 3 inclusion and 3 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: looking for participants now, as of the sponsor's last update on 23 Jul 2026. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in United States. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

This study is still under way. Results are not available in the source record yet.

How can a doctor refer a patient or contact the research team?

Contact Amir Goren, PhD (570-214-4395, agoren@geisinger.edu), or a site near the patient. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Return to Geisinger ED (time frame: within 120 days following day of discharge). It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 23 Jul 2026.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in